Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Rio Tinto (RIO) a Buy on Strong Earnings Visibility

By Portfolio Grader
Rio Tinto Plc (NYSE:RIO) is ranked as a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. This represents no change from the previous week and is the same ranking RIO has had from Portfolio Grader for 4 months.

BHP Billiton (BHP) Sees Downgrade….. Weakening Sales Growth

By Portfolio Grader
The current recommendation of Hold for BHP Billiton Ltd (NYSE:BHP) has been derived by using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current overall Portfolio Grader recommendation on the shares has changed twice in the past month, which represents a greater level of change than is typical.

Goodyear Tire & Rubber Co (GT) Stock Skids on Falling Q3 Profit

By William White, InvestorPlace Writer
Goodyear (GT) stock was falling on Friday following the release of its earnings report for the third quarter of the year.

Statoil ASA (STO) a Buy on Robust Earnings Visibility

By Portfolio Grader
Statoil ASA (NYSE:STO) ranks in the top 10% of its industry group, Oil Gas & Consumable Fuels, and in the top 10% of its sector group, Energy, with a market value of $67.1 billion. From an investment attractiveness vantage point, STO is ranked in the top decile of the sector with a ranking of 12 among the 362 companies in the sector; the stock's current Portfolio Grader score places it 12 among the 290 companies in this industry group, positioning it among the leaders and number 527 in the 5000 company Portfolio Grader company universe.

Vodafone Group (VOD) a Buy on Strong Quant Score

By Portfolio Grader
Currently, Vodafone Group Plc (NASDAQ:VOD) has a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. VOD has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

AbbVie Inc (ABBV) Earnings: 12 Things to Know

By William White, InvestorPlace Writer
AbbVie (ABBV) has released its earnings report for the third quarter of 2017 and 'InvestorPlace' has a few things to know about it.

DowDuPont’s (DWDP) Strong Sales Growth Makes it a Buy

By Portfolio Grader
With a $87.1 billion market value, DowDuPont Inc (NULL:DWDP) ranks in the top decile in its industry group, Chemicals, and in the top decile of sector group, Materials, in market value. From the vantage point of investment attractiveness, the ranking for DWDP by Portfolio Grader places it 25 among the 95 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 84 among the 269 companies in the sector, and number 1,290 in the nearly 5,000 company Portfolio Grader universe.

NTT Docomo (DCM) a Buy on Superior Quant Score

By Portfolio Grader
NTT Docomo Inc (NYSE:DCM) is ranked as a Buy using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. DCM has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Merck & Co., Inc. (MRK) Takes a Hit After Q3 Loss

By William White, InvestorPlace Writer
Merck (MRK) stock took a hit on Friday following a poor sowing in its earnings report for the third quarter of the year.

Analysis of Quant Score Keeps Schlumberger (SLB) a Sell

By Portfolio Grader
Currently, Schlumberger NV (NYSE:SLB) has a Sell using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking SLB has had from Portfolio Grader for 3 months.

6 Undervalued Stocks That Top Money Managers Are Buying

By Matt Hogan, Founder, Finbox.io
One of the better-kept secrets in investing is a form called the 13F-HR that all institutional investors who manage over $100 million in assets must…

Earnings Growth Restricts AstraZeneca (AZN) Rating

By Portfolio Grader
Portfolio Grader currently ranks AstraZeneca Plc (NYSE:AZN) a Hold. Using Louis Navellier's investing methodology, this analytical tool assesses stocks with fundamental and quantitative analytical tools. AZN has maintained this ranking for the last month.

J C Penney Company Inc (JCP) Cuts Forecast, Stock Tanks

By William White, InvestorPlace Writer
JC Penney (JCP) took a beating today after the company lowered its guidance for the third quarter of 2017 to below estimates.

Earnings Momentum Penalizes Eli Lilly (LLY) Rating

By Portfolio Grader
Currently, Eli Lilly and Company (NYSE:LLY) has a Hold using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for 7 months.

Novo Nordisk A/S’s (NVO) Solid Quant Score Makes it a Buy

By Portfolio Grader
The current recommendation of Buy for Novo Nordisk A/S (NYSE:NVO) is derived using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. The current Portfolio Grader recommendation on the shares has been in place for the last month.

GlaxoSmithKline (GSK) Earnings Momentum Penalizes Rating

By Portfolio Grader
The current recommendation of Hold for GlaxoSmithKline Plc (NYSE:GSK) is computed using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. GSK has recently seen its Portfolio Grader rating upgraded from a Sell to a Hold.

Bristol-Myers Squibb Co’s (BMY) Solid Quant Score Keeps it a Buy

By Portfolio Grader
The current recommendation of Buy for Bristol-Myers Squibb Co (NYSE:BMY) is derived using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. BMY has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Why You Should Care About a CVS Health Corp Buyout of Aetna Inc

By Dana Blankenhorn, InvestorPlace Contributor
CVS and Aetna will be able to link healthcare income to healthcare outgo, which would be a big win for CVS stock owners.

High-Level Measures for Earnings Momentum Make Sanofi (SNY) a Strong Buy

By Portfolio Grader
The current recommendation of Strong Buy for Sanofi SA (NYSE:SNY) is the result of using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing approach. SNY has maintained this ranking for 2 months.
Load More Articles